INTERNATIONAL PATENT: BIOHAVEN THERAPEUTICS LTD. FILES APPLICATION FOR "TARGETED DEGRADATION OF ANTI-AAV ANTIBODIES TO ENABLE AAV-BASED GENE THERAPY"

GENEVA, Feb. 9 -- BIOHAVEN THERAPEUTICS LTD. (P.O. Box 173Kingston ChambersRoad TownTortola, VG1110) filed a patent application (PCT/IB2025/057821) for "TARGETED DEGRADATION OF ANTI-AAV ANTIBODIES TO ENABLE AAV-BASED GENE THERAPY" on Jul 31, 2025. With publication no. WO/2026/028158, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OPPIKOFER, Mariano (Biohaven Pharmaceuticals, Inc.215 Church StreetNew Haven, Connecticut 06510), INGALE, Sampat (Biohaven Pharmaceuticals, Inc.215 Church StreetNew Haven, Connecticut 06510), VA...